Get started
BioCardia, Inc.BioCardia, Inc.BioCardia, Inc.

BioCardia, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

BCDA chart


Full chart

BCDA upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪9.17 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−4.16 USD
Net income (FY)
‪−11.57 M‬ USD
Revenue (FY)
‪477.00 K‬ USD
Shares float
‪3.80 M‬
Beta (1Y)
2.86

Employees


Employees (FY)
20
Change (1Y)
−16 −44.44%
Revenue / Employee (1Y)
‪23.85 K‬ USD
Net income / Employee (1Y)
‪−578.55 K‬ USD

About BioCardia, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Peter Alan Altman
Website
biocardia.com
Headquarters
Sunnyvale
Founded
1994
FIGI
BBG000BTJTF3
BioCardia, Inc. is a clinical-stage biotherapeutic company. It engages in the business of developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. The company was founded on January 12, 1994 and is headquartered in Sunnyvale, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

BCDA news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of BCDA is 2.09 USD — it has decreased by −0.50% in the past 24 hours. Watch BioCardia, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange BioCardia, Inc. stocks are traded under the ticker BCDA.
BCDA stock has fallen by −4.76% compared to the previous week, the month change is a −14.16% fall, over the last year BioCardia, Inc. has showed a −78.33% decrease.
We've gathered analysts' opinions on BioCardia, Inc. future price: according to them, BCDA price has a max estimate of 25.00 USD and a min estimate of 25.00 USD. Watch BCDA chart and read a more detailed BioCardia, Inc. stock forecast: see what analysts think of BioCardia, Inc. and suggest that you do with its stocks.
BCDA reached its all-time high on Feb 23, 2000 with the price of 78,501.71 USD, and its all-time low was 1.63 USD and was reached on Dec 19, 2024. View more price dynamics on BCDA chart.
See other stocks reaching their highest and lowest prices.
BCDA stock is 12.90% volatile and has beta coefficient of 2.86. Track BioCardia, Inc. stock price on the chart and check out the list of the most volatile stocks — is BioCardia, Inc. there?
Yes, you can track BioCardia, Inc. financials in yearly and quarterly reports right on TradingView.
BioCardia, Inc. is going to release the next earnings report on Apr 1, 2025. Keep track of upcoming events with our Earnings Calendar.
BCDA earnings for the last quarter are −0.61 USD per share, whereas the estimation was −1.19 USD resulting in a 48.74% surprise. The estimated earnings for the next quarter are −0.87 USD per share. See more details about BioCardia, Inc. earnings.
BioCardia, Inc. revenue for the last quarter amounts to 0.00 USD, despite the estimated figure of ‪200.00 K‬ USD. In the next quarter, revenue is expected to reach ‪20.00 K‬ USD.
BCDA net income for the last quarter is ‪−1.74 M‬ USD, while the quarter before that showed ‪−1.65 M‬ USD of net income which accounts for −5.53% change. Track more BioCardia, Inc. financial stats to get the full picture.
No, BCDA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 26, 2024, the company has 20.00 employees. See our rating of the largest employees — is BioCardia, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BioCardia, Inc. EBITDA is ‪−7.34 M‬ USD, and current EBITDA margin is ‪−2.35 K‬%. See more stats in BioCardia, Inc. financial statements.
Like other stocks, BCDA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BioCardia, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BioCardia, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BioCardia, Inc. stock shows the sell signal. See more of BioCardia, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.